Effects of embryotoxic chemicals on the in vitro differentiation of genetically engineered embryonic stem cells into cardiac cells

Toxicology in Vitro

Volumn 13, Issue 4-5, 1999, Pages 645-650

  Bremer, S ^a   Van Dooren, M ^a   Paparella, M ^a   Kossolov, E ^b   Fleischmann, B K ^b   Hescheler, J ^b  

^a JOINT RESEARCH CENTRE   (Italy)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

5 fluorouracil; Cardiac cell differentiation in vitro; Embryonic stem cells; Embryotoxicology; Green fluorescent protein; Hydroxyurea

Indexed keywords

FLUOROURACIL; GREEN FLUORESCENT PROTEIN; HYDROXYUREA; RETINOIC ACID;

CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; EMBRYOTOXICITY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; STEM CELL;

EID: 0032839440     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(99)00056-9     Document Type: Conference Paper

References (19)

1. Brown N.A., Wiger R. A comparison of rat and chick limb bud micromass cultures for developmental toxicity screening. Toxicology in Vitro. 6:1992;101-108.
2. Chalfie M., Tu Y., Euskirchen G., Ward W.W., Prasher D.C. Green fluorescence protein as a marker for gene expression. Science. 263:1994;802-805.
3. Cody C., Prasher D.C., Westler W.M., Prendergast F.G., Ward W.W. Chemical structure of the hexapeptide chromophore of the Aequorea green-fluorescent protein. Biochemistry. 32:1993;1212-1218.
4. Doetschmann T.C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of viceral yolk sac, blood islands and myocardium. Journal of Embryology and Experimental Morphology. 87:1985;27-45.
5. Ferencz C., Rubin J.D., McCarter R.J. Congenital heart disease: prevalence at livebirth: the Baltimore-Washington Infant Study. American Journal of Epidemiology. 121:1985;31-36.
6. Flint O.P., Orton T., Ferguson R.A. Differentiation of rat embryo cells in culture: response following acute maternal exposure to teratogens and non-teratogens. Journal of Applied Toxicology. 4:1984;109-116.
7. Flint O.P. In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test. Reproductive Toxicology. 7:(Suppl. 1):1993;103-111.
8. Fyler D.C. Report of the New England Regional Infant Cardiac Program. Pediatrics. 65:(suppl.):1980;375-461.
9. Kolossov E., Fleischmann B.K., Liu Q., Bloch W., Viatchenko-Karpinski S., Manzke O., Ji G.J., Bohlen H., Addicks K., Hescheler J. Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue specific expression of the Green Fluorescent Protein. Journal of Cell Biology. 143:1998;2045-2056.
10. Lammer E.J., Chen D.T., Hoar R.M., Agnish N.D., Benke P.J., Braun J.T., Curry C.J., Fernhoff P.M., Grix A.W., Lott I.T., Richard J.M., Sun S.C. Retinoic acid embryopathy. New England Journal of Medicine. 313:1985;837-841.
11. Lederer J., Pottier-Arnauld A.M. Toxicity of sodium cyclamate and saccharin for the offspring of pregnant mice. Diabetes. 17:1969;103-106.
12. Li X., Zhang G., Ngo N., Zhao X., Kain S.R., Huang C.C. Deletions of the Aequorea victoria green fluorescent protein define the minimal domain required for fluorescence. Journal of Biological Chemistry. 272:1997;28545-28549.
13. Metzger J.M., Lin W.I., Samuelson L.C. Vital staining of cardiac myocytes during embryonic stem cell cardiogenesis in vitro. Circulation Research. 78:1996;547-552.
14. Prasher D.C., Eckenrode V.K., Ward W.W., Prendergast F.G., Cornier M.J. Primary structure of the Aequorea victoria green-fluorecent protein. Gene. 111:1992;229-233.
15. Robbins J., Gulick J., Sanchez A., Howles P., Doetschmann T. Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. Journal of Biological Chemistry. 265:1990;11905-11909.
16. Sartorelli V., Hong N. A., Bishobric N. H. and Kedes L. (1992) Myocardial activation of the human cardiac alpha-actin promotor by helix-loop-helix proteins. Proceedings of the National Academy of Sciences of the U.S.A. 89, 4047-4051.
17. Scholz G., Pohl I., Seiler A., Bremer S., Brown N., Piersma A., Holzhuetter H., Spielmann H. Ergebnisse der ersten Phase des ECVAM-Projektes zur Praevalidierung und Validierung von drei in vitro Embryotoxicitaetests. Altex. 15:1998;3-8.
18. Stephens J.D., Golbus M.S., Miller T.R., Wilber R.R., Epstein C.J. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester. American Journal of Obstetrics and Gynecology. 137:1980;747-748.
19. Wobus A.M., Rohwedel J., Maltsev V., Hescheler J. In vitro cellular models for cardiac development and pharmacotoxicology. Toxicology in Vitro. 9:1995;477-488.